Clinical Trial Update: A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/2 clinical trial evaluated the safety and efficacy of ZPL-5212372 in healthy subjects and in patients with atopic dermatitis; results have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• ZPL-5212372

Snippet

Sponsor: Ziarco Pharma Ltd | Conditions: Atopic Dermatitis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-04-05